ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00124527
Recruitment Status : Completed
First Posted : July 28, 2005
Last Update Posted : November 7, 2008
Sponsor:
Information provided by:
Eisai Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given